![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
01 Dr. Reddy\'s Laboratories (8)
02 Actavis Inc (2)
03 Alembic Pharmaceuticals Limited (4)
04 ENDO OPERATIONS (4)
05 ORIFARM GROUP AS (1)
06 OrPha Swiss GmbH (2)
07 Sandoz B2B (4)
08 Teva Pharmaceutical Industries (4)
09 United Therapeutics (33)
01 INFUSIONSVÄTSKA, LÖSNING (5)
02 INJECTABLE;IV (INFUSION), SUBCUTANEOUS (28)
03 Infusion (2)
04 Infusion fluid, resolution (4)
05 Injection (4)
06 POWDER;INHALATION (4)
07 SOLUTION (4)
08 SOLUTION;INHALATION (1)
09 SOLUTION;INTRAVENOUS, SUBCUTANEOUS (4)
10 TABLET, EXTENDED RELEASE;ORAL (2)
11 Treprostinil 100Mg 20Ml 1 Units Parenteral Use (1)
12 Treprostinil 200Mg 20Ml 1 Units Parenteral Use (1)
13 Treprostinil 20Mg 20Ml 1 Units Parenteral Use (1)
14 Treprostinil 50Mg 20Ml 1 Units Parenteral Use (1)
01 DISCN (4)
02 Lead Market Dossiers- Filed (4)
03 Prescription (4)
04 RX (33)
05 Blank (17)
01 REMODULIN (16)
02 Remodulin (13)
03 TREPROSTINIL (22)
04 TYVASO (1)
05 TYVASO DPI (4)
06 Blank (6)
01 Canada (4)
02 India (4)
03 Italy (4)
04 Norway (4)
05 Sweden (5)
06 Switzerland (2)
07 USA (39)